WELL Health Technologies Corp. (TSE:WELL – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is C$6.96.
Separately, CIBC upped their price target on WELL Health Technologies from C$4.75 to C$5.00 in a research note on Friday, August 16th.
View Our Latest Stock Report on WELL
WELL Health Technologies Stock Performance
WELL Health Technologies Company Profile
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
See Also
- Five stocks we like better than WELL Health Technologies
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- Transportation Stocks Investing
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- Learn Technical Analysis Skills to Master the Stock Market
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.